Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Thor A. Skovsted, Eva Rabing Brix Petersen, Maj-Britt Fruekilde, Andreas Kristian Pedersen, Tomasz Pielak & Jesper Eugen-Olsen. (2020) Validation of suPAR turbidimetric assay on Cobas® (c502 and c702) and comparison to suPAR ELISA. Scandinavian Journal of Clinical and Laboratory Investigation 80:4, pages 327-335.
Read now
Read now
Melis Sirinoglu, Ahmet Soysal, Ayşe Karaaslan, Eda Kepenekli Kadayifci, Ismail Cinel, Ahmet Koç, Gülnur Tokuç, Ali Yaman, Goncagül Haklar, Önder Şirikçi, Serap Turan, Gülşen Altınkanat Gelmez, Güner Söyletir & Mustafa Bakır. (2016) The diagnostic value of soluble urokinase plasminogen activator receptor compared with C-reactive protein and procalcitonin in children with febrile neutropenia. Pediatric Hematology and Oncology 33:3, pages 200-208.
Read now
Read now
Aziz Gumus, Nejat Altintas, Halit Cinarka, Aynur Kirbas, Muge Hazıroglu, Mevlut Karatas & Unal Sahin. (2015) Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 357-365.
Read now
Read now
Mary Sandquist & Hector R Wong. (2014) Biomarkers of sepsis and their potential value in diagnosis, prognosis and treatment. Expert Review of Clinical Immunology 10:10, pages 1349-1356.
Read now
Read now
Gergely Toldi, Balázs Szalay, Gabriella Bekő, Márta Bocskai, Magdolna Deák, László Kovács, Barna Vásárhelyi & Attila Balog. (2012) Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in systemic lupus erythematosus. Biomarkers 17:8, pages 758-763.
Read now
Read now
Manuela Nebuloni, Paola Cinque, Nicolai Sidenius, Angelita Ferri, Eleonora Lauri, Elisabetta Omodeo-Zorini, Pietro Zerbi & Luca Vago. (2009) Expression of the urokinase plasminogen activator receptor (uPAR) and its ligand (uPA) in brain tissues of human immunodeficiency virus patients with opportunistic cerebral diseases. Journal of Neurovirology 15:1, pages 99-107.
Read now
Read now
Articles from other publishers (48)
Atul Kakar, Sangeeta Choudhury, Ved Chaturvedi, Shikhar Tripathi, Pooja Rani Rajput & Rizwana Hasan. (2024) Utility of sUPAR as a Novel Biomarker for Stratifying Rheumatoid Arthritis Patients in Remission. Annals of Rheumatology and Autoimmunity 4:1, pages 14-18.
Crossref
Crossref
Syeda Tayyaba Rehan, Hassan ul Hussain, Eman Ali, Kanwal Ashok Kumar, Shehroze Tabassum, Muhammad Hasanain, Asim Shaikh, Gibran Ali, Zohaib Yousaf & Muhammad Sohaib Asghar. (2023) Role of soluble urokinase type plasminogen activator receptor (suPAR) in predicting mortality, readmission, length of stay and discharge in emergency patients: A systematic review and meta analysis. Medicine 102:45, pages e35718.
Crossref
Crossref
Huriye Erbak Yılmaz, Saliha Aksun, Süleyman Günay, Ferhan Elmalı & Cem Çekiç. (2023) Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis. Arab Journal of Gastroenterology 24:3, pages 175-179.
Crossref
Crossref
Veselina Stefanova, Valerie M. Crowley, Andrea M. Weckman & Kevin C. Kain. (2022) suPAR to Risk-Stratify Patients With Malaria. Frontiers in Immunology 13.
Crossref
Crossref
Tomasz Skalec, Barbara Adamik, Katarzyna Kobylinska & Waldemar Gozdzik. (2022) Soluble Urokinase-Type Plasminogen Activator Receptor Levels as a Predictor of Kidney Replacement Therapy in Septic Patients with Acute Kidney Injury: An Observational Study. Journal of Clinical Medicine 11:6, pages 1717.
Crossref
Crossref
Tobias P. Schmidt, Walid Albanna, Miriam Weiss, Michael Veldeman, Catharina Conzen, Omid Nikoubashman, Christian Blume, Daniel S. Kluger, Hans Clusmann, Sven H. Loosen & Gerrit A. Schubert. (2022) The Role of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Context of Aneurysmal Subarachnoid Hemorrhage (aSAH)—A Prospective Observational Study. Frontiers in Neurology 13.
Crossref
Crossref
Line Jee Hartmann Rasmussen, Jens Emil Vang Petersen & Jesper Eugen-Olsen. (2021) Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation. Frontiers in Immunology 12.
Crossref
Crossref
Kadir KÜÇÜKCERAN, Omer KARASAHİN, Orhan DELİCE, Ali BATUR, Sibel İBA YILMAZ, Engin ŞEBİN & Mahmut ŞENYURT. (2021) The Diagnostic Value of Soluble Urokinase Plasminogen Activator Receptor in Crimean-Congo Hemorrhagic Fever Disease in Emergency DepartmentAcil Serviste Kırım Kongo Kanamalı Ateş Hastalığında Soluble Ürokinaz Plazminojen Aktivatör Reseptörünün Tanısal Değeri. Düzce Tıp Fakültesi Dergisi 23:1, pages 15-19.
Crossref
Crossref
İsmail Taşdemir, Huriye Erbak Yılmaz, Figen Narin & Mehmet Sağlam. (2020) Assessment of saliva and gingival crevicular fluid soluble urokinase plasminogen activator receptor (suPAR), galectin‐1, and TNF‐α levels in periodontal health and disease. Journal of Periodontal Research 55:5, pages 622-630.
Crossref
Crossref
Jens Emil Vang Petersen, Thomas Kallemose, Karen D Barton, Avshalom Caspi & Line Jee Hartmann Rasmussen. (2020) Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis. BMJ Open 10:7, pages e036125.
Crossref
Crossref
Jan Simon Scharrenberg, Ayla Yagdiran, Julia Brinkmann, Maik Brune, Jan Siewe, Norma Jung & Esther Mahabir. (2019) The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine. Journal of Orthopaedic Surgery and Research 14:1.
Crossref
Crossref
Dan Chen, Xiaoling Wu, Junhui Yang & Li Yu. (2019) Serum plasminogen activator urokinase receptor predicts elevated risk of acute respiratory distress syndrome in patients with sepsis and is positively associated with disease severity, inflammation and mortality. Experimental and Therapeutic Medicine.
Crossref
Crossref
Peter Polzik, Olav Grøndal, Juliette Tavenier, Martin B. Madsen, Ove Andersen, Morten Hedetoft & Ole Hyldegaard. (2019) SuPAR correlates with mortality and clinical severity in patients with necrotizing soft-tissue infections: results from a prospective, observational cohort study. Scientific Reports 9:1.
Crossref
Crossref
Ding Long, Yujun Wang, Hui Wang, Xiaoling Wu & Li Yu. (2019) Correlation of Serum and Ascitic Fluid Soluble Form Urokinase Plasminogen Activator Receptor Levels With Patient Complications, Disease Severity, Inflammatory Markers, and Prognosis in Patients With Severe Acute Pancreatitis. Pancreas 48:3, pages 335-342.
Crossref
Crossref
Pratyush Kumar, Atul Kakar, Atul Gogia & NIamatullah Waziri. (2019) Evaluation of soluble urokinase-type plasminogen activator receptor (suPAR) quick test for triage in the emergency department. Journal of Family Medicine and Primary Care 8:12, pages 3871.
Crossref
Crossref
Melis Şirinoğlu, Ahmet Soysal, Ayşe Karaaslan, Eda Kepenekli Kadayifci, Nilüfer Yalındağ-Öztürk, İsmail Cinel, Ali Yaman, Goncagül Haklar, Önder Şirikci, Serap Turan, Gülşen Altınkanat Gelmez, Güner Söyletir & Mustafa Bakır. (2017) The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS). Journal of Infection and Chemotherapy 23:1, pages 17-22.
Crossref
Crossref
Andreas Kronbichler, Moin A. Saleem, Björn Meijers & Jae Il Shin. (2016) Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View. Journal of Immunology Research 2016, pages 1-14.
Crossref
Crossref
Ivo Casagranda, Chiara Vendramin, Tiziana Callegari, Matteo Vidali, Alessandra Calabresi, Giovanna Ferrandu, Gianfranco Cervellin, Mario Cavazza, Giuseppe Lippi, Isabella Zanotti, Sophie Negro, Andrea Rocchetti & Carlo Arfini. (2015) Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department. Internal and Emergency Medicine 10:6, pages 725-730.
Crossref
Crossref
Waldemar Gozdzik, Barbara Adamik, Anna Gozdzik, Maciej Rachwalik, Wojciech Kustrzycki & Andrzej Kübler. (2014) Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use. PLoS ONE 9:6, pages e98923.
Crossref
Crossref
Katia Donadello, Sabino Scolletta, Fabio Silvio Taccone, Cecilia Covajes, Cristina Santonocito, Diego Orbegozo Cortes, Daiva Grazulyte, Leonardo Gottin & Jean-Louis Vincent. (2014) Soluble urokinase–type plasminogen activator receptor as a prognostic biomarker in critically ill patients. Journal of Critical Care 29:1, pages 144-149.
Crossref
Crossref
Thomas H. HauptThomas KallemoseSteen LadelundLine J. H. RasmussenChristian W. ThorballOve AndersenCharlotta PisingerJesper Eugen-Olsen. (2014) Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population. Biomarker Insights 9, pages BMI.S19876.
Crossref
Crossref
Tuula K. Outinen, Laura Tervo, Satu Mäkelä, Reetta Huttunen, Niina Mäenpää, Heini Huhtala, Antti Vaheri, Jukka Mustonen & Janne Aittoniemi. (2013) Plasma Levels of Soluble Urokinase-Type Plasminogen Activator Receptor Associate with the Clinical Severity of Acute Puumala Hantavirus Infection. PLoS ONE 8:8, pages e71335.
Crossref
Crossref
István Ivancsó, Gergely Toldi, Anikó Bohács, Noémi Eszes, Veronika Müller, János Rigó, Barna Vásárhelyi, György Losonczy & Lilla Tamási. (2013) Relationship of Circulating Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels to Disease Control in Asthma and Asthmatic Pregnancy. PLoS ONE 8:4, pages e60697.
Crossref
Crossref
Gergely Toldi, Balázs Szalay, Gabriella Bekő, László Kovács, Barna Vásárhelyi & Attila Balog. (2013) Taux plasmatiques du récepteur soluble de l’urokinase plasminogène activateur (suPAR) dans la spondylarthrite ankylosante. Revue du Rhumatisme 80:2, pages 179-182.
Crossref
Crossref
Gergely Toldi, Gabriella Bekő, Gabriella Kádár, Emília Mácsai, László Kovács, Barna Vásárhelyi & Attila Balog. (2013) Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission. Clinical Chemistry and Laboratory Medicine (CCLM) 51:2, pages 327-332.
Crossref
Crossref
M. Mussap, A. Noto, F. Cibecchini & V. Fanos. (2013) The importance of biomarkers in neonatology. Seminars in Fetal and Neonatal Medicine 18:1, pages 56-64.
Crossref
Crossref
Gergely Toldi, Balázs Szalay, Gabriella Bekő, László Kovács, Barna Vásárhelyi & Attila Balog. (2013) Plasma soluble urokinase plasminogen activator receptor (suPAR) levels in ankylosing spondylitis. Joint Bone Spine 80:1, pages 96-98.
Crossref
Crossref
A. Wrotek, K. Pawlik & T. Jackowska. 2013. Neurobiology of Respiration. Neurobiology of Respiration
329
334
.
Katia Donadello, Sabino Scolletta, Cecilia Covajes & Jean-Louis Vincent. (2012) suPAR as a prognostic biomarker in sepsis. BMC Medicine 10:1.
Crossref
Crossref
R. Uusitalo‐Seppälä, R. Huttunen, M. Tarkka, J. Aittoniemi, P. Koskinen, A. Leino, T. Vahlberg & E. M. Rintala. (2012) Soluble urokinase‐type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study. Journal of Internal Medicine 272:3, pages 247-256.
Crossref
Crossref
Jochen Reiser, Changli Wei & James Tumlin. (2012) Soluble urokinase receptor and focal segmental glomerulosclerosis. Current Opinion in Nephrology and Hypertension 21:4, pages 428-432.
Crossref
Crossref
G. Tzanakaki, M. Paparoupa, M. Kyprianou, A. Barbouni, J. Eugen-Olsen & J. Kourea-Kremastinou. (2011) Elevated soluble urokinase receptor values in CSF, age and bacterial meningitis infection are independent and additive risk factors of fatal outcome. European Journal of Clinical Microbiology & Infectious Diseases 31:6, pages 1157-1162.
Crossref
Crossref
R. Huttunen, J. Syrjänen, R. Vuento, M. Hurme, H. Huhtala, J. Laine, T. Pessi & J. Aittoniemi. (2011) Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. Journal of Internal Medicine 270:1, pages 32-40.
Crossref
Crossref
E. Haastrup, J. Andersen, S. R. Ostrowski, G. Høyer‐Hansen, N. Jacobsen, C. Heilmann, H. Ullum & K. Müller. (2011) Soluble Urokinase Plasminogen Activator Receptor During Allogeneic Stem Cell Transplantation. Scandinavian Journal of Immunology 73:4, pages 325-329.
Crossref
Crossref
Anna GustafssonVjosa AjetiLennart Ljunggren. (2011) Detection of suPAR in the Saliva of Healthy Young Adults: Comparison with Plasma Levels. Biomarker Insights 6, pages BMI.S8326.
Crossref
Crossref
Per WittenhagenJesper Brandt AndersenAnita HansenLone LindholmFrederik RønneJørn TheilMichael TvedeJesper Eugen-Olsen. (2011) Plasma Soluble Urokinase Plasminogen Activator Receptor in Children with Urinary Tract Infection. Biomarker Insights 6, pages BMI.S6876.
Crossref
Crossref
Gergely Toldi, Edina Bíró, Balázs Szalay, Balázs Stenczer, Attila Molvarec, János Rigó, Barna Vásárhelyi & Gabriella Bekõ. (2011) Soluble urokinase plasminogen activator receptor (suPAR) levels in healthy pregnancy and preeclampsia. Clinical Chemistry and Laboratory Medicine 49:11.
Crossref
Crossref
Yara Backes, Koenraad F van der Sluijs, Anita M Tuip de Boer, Jorrit Jan Hofstra, Alexander PJ Vlaar, Rogier M Determann, Paul Knape, David P Mackie & Marcus J Schultz. (2011) Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study. Critical Care 15:6, pages R270.
Crossref
Crossref
Alexander Koch, Sebastian Voigt, Carsten Kruschinski, Edouard Sanson, Hanna Dückers, Andreas Horn, Eray Yagmur, Henning Zimmermann, Christian Trautwein & Frank Tacke. (2011) Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care 15:1, pages R63.
Crossref
Crossref
Shinta Oktya Wardhani, Niniek Burhan, Gatoet Ismanoe & Tri Yudani. (2010) Correlation between soluble urokinase plasminogen activator receptor with CD4 T lymphocyte and WHO clinical staging of HIV infection. Indonesian Journal of Tropical and Infectious Disease 1:1, pages 32.
Crossref
Crossref
Boris K. Pliyev & Mikhail Yu. Menshikov. (2009) Release of the Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) by Activated Neutrophils in Rheumatoid Arthritis. Inflammation 33:1, pages 1-9.
Crossref
Crossref
Børre Fevang, Jesper Eugen-Olsen, Arne Yndestad, Frank Brosstad, Klaus Beiske, Pål Aukrust & Stig S Frøland. (2009) Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. Clinical Immunology 131:3, pages 438-446.
Crossref
Crossref
Stephen F. Kingsmore, Neil Kennedy, Henry L. Halliday, Jennifer C. Van Velkinburgh, Shengiang Zhong, Vanessa Gabriel, Judith Grant, William D. Beavis, Velizar T. Tchernev, Lorah Perlee, Serguei Lejnine, Brian Grimwade, Martin Sorette & J. David M. Edgar. (2008) Identification of Diagnostic Biomarkers for Infection in Premature Neonates. Molecular & Cellular Proteomics 7:10, pages 1863-1875.
Crossref
Crossref
K. Kofoed, J. Eugen-Olsen, J. Petersen, K. Larsen & O. Andersen. (2008) Predicting mortality in patients with systemic inflammatory response syndrome: an evaluation of two prognostic models, two soluble receptors, and a macrophage migration inhibitory factor. European Journal of Clinical Microbiology & Infectious Diseases 27:5, pages 375-383.
Crossref
Crossref
Mads N. SvendsenHenriette YttingNils BrünnerHans J. NielsenIB J. Christensen. (2006) Preoperative Concentrations of suPAR and MBL Proteins Are Associated with the Development of Pneumonia after Elective Surgery for Colorectal Cancer. Surgical Infections 7:5, pages 463-471.
Crossref
Crossref
Kristian Kofoed, Uffe Vest Schneider, Troels Scheel, Ove Andersen & Jesper Eugen-Olsen. (2006) Development and Validation of a Multiplex Add-On Assay for Sepsis Biomarkers Using xMAP Technology. Clinical Chemistry 52:7, pages 1284-1293.
Crossref
Crossref
Nicolai Sidenius, Manuela Nebuloni, Stefania Sala, Pietro Zerbi, Richard W. Price, Magnus Gisslen, Lars Hagberg, Luca Vago, Adriano Lazzarin, Francesco Blasi & Paola Cinque. (2004) Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease. Journal of Neuroimmunology 157:1-2, pages 133-139.
Crossref
Crossref
Nathalie Beaufort, Dominique Leduc, Jean-Claude Rousselle, Abdelkader Namane, Michel Chignard & Dominique Pidard. (2004) Plasmin cleaves the juxtamembrane domain and releases truncated species of the urokinase receptor (CD87) from human bronchial epithelial cells. FEBS Letters 574:1-3, pages 89-94.
Crossref
Crossref